The classical pathways involved in the generation of advanced glycosylation end products, the activation of protein kinase C, and the aldose reductase pathway, contribute to the development of DN, in which oxidative stress appears to be a common result. The gene discussed is AKR1B1; the disease is liver dysplastic nodule.